Ross Vimr, MD
Interventional Cardiology · Clackamas, ORNPI 1467719641
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 79.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $7,104 and has fallen 94.8% since, to $368 in 2025.
Across 86 payments — averaging $126.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Edwards Lifesciences$726
- Abbott$595
- Biotronik Inc.$294
- Cardiovascular Systems Inc.$151
- Shockwave Medical, Inc$151
- plus $295 from 5 others
What the payments were for
- Grants$6,50060%
- Travel & lodging$1,20611%
- Food & beverage$2,96027%
- Education$2102%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 25 | $8,664 |
| Edwards Lifesciences | 24 | $726 |
| Abbott | 8 | $595 |
| Biotronik Inc. | 14 | $294 |
| Cardiovascular Systems Inc. | 2 | $151 |
| Shockwave Medical, Inc | 3 | $151 |
| W. L. Gore & Associates, Inc. | 1 | $138 |
| Philips North America LLC | 2 | $56 |
| Abiomed | 2 | $51 |
| Penumbra, Inc. | 4 | $30 |
| Terumo Medical Corporation | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,876 in reported general payments places this provider in the 65th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 147 | $65,495 |
| EliquisApixaban | 29 | $33,731 |
| BrilintaTicagrelor | 57 | $32,451 |
| EntrestoSacubitril/Valsartan | 16 | $17,611 |
| PradaxaDabigatran Etexilate Mesylate | 53 | $13,693 |
| Repatha SureclickEvolocumab | 12 | $7,213 |
| ClopidogrelClopidogrel Bisulfate | 251 | $4,011 |
| Metoprolol Succinate | 158 | $2,099 |
| Spironolactone | 151 | $1,443 |
| Rosuvastatin Calcium | 123 | $1,335 |
| Amiodarone Hcl | 43 | $1,208 |
| Flecainide Acetate | 31 | $1,197 |
| Carvedilol | 82 | $928 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 75 | $890 |
| Losartan Potassium | 78 | $817 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Clackamas
- Keaton NasserClackamas$41K
- Abhimanyu UberoiClackamas$41K
- Jason WollmuthPortland$749K
- Saurabh GuptaBend$550K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
- Harsh GolwalaPortland$105K
- Brandon JonesPortland$101K
- Sudeshna BanerjeeSpringfield$66K
- Kathryn DawsonPortland$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.